<!DOCTYPE html>
<html lang="zh">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Identification of optimal biomarkers associated with distant metastasis inbreast cancer using Boruta and Lasso machine learning algorithms - PMC</title>
  <style>
    body {
      font-family: "Helvetica Neue", "Noto Sans TC", sans-serif;
      max-width: 720px;
      margin: 2em auto;
      padding: 0 1em;
      color: #333;
      line-height: 1.8;
      background: #fff;
    }
    h1, h2, h3 {
      text-align: center;
      color: #222;
    }
    .lang-switcher {
      text-align: center;
      margin-bottom: 2em;
    }
    .lang-btn {
      margin: 0 0.5em;
      padding: 0.4em 1em;
      border: none;
      background-color: #eee;
      border-radius: 4px;
      cursor: pointer;
      font-weight: bold;
    }
    .lang-btn.active {
      background-color: #007acc;
      color: white;
    }
    ul {
      padding-left: 1.2em;
    }
    a {
      color: #007acc;
      text-decoration: none;
    }
    a:hover {
      text-decoration: underline;
    }
    img {
      max-width: 100%;
      height: auto;
    }
    .share-block {
      text-align: center;
      margin: 1em 0 2em;
      font-size: 0.95em;
    }
    .share-block a svg {
      width: 24px;
      height: 24px;
      display: inline-block;
      vertical-align: middle;
      margin: 0 0.4em;
      transition: transform 0.2s ease;
      cursor: pointer;
    }
    .share-block a svg:hover {
      transform: scale(1.2);
    }
  </style>
</head>
<body>
  <h1>Identification of optimal biomarkers associated with distant metastasis inbreast cancer using Boruta and Lasso machine learning algorithms - PMC</h1>
  
  <div class="share-block">
    <span>ğŸ”— åˆ†äº«é€™ç¯‡SEOï¼š</span>
    <a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fbreastcancer-tech.github.io%2Fbreast-cancer-1%2Fidentification-of-optimal-biomarkers-associated-with-distant-metastasis-inbreast-cancer-using-boruta-and-lasso-machine-learning-algorithms-pmc-seo.html" target="_blank" title="Facebook">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--!Font Awesome Free 6.7.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2025 Fonticons, Inc.--><path d="M512 256C512 114.6 397.4 0 256 0S0 114.6 0 256C0 376 82.7 476.8 194.2 504.5V334.2H141.4V256h52.8V222.3c0-87.1 39.4-127.5 125-127.5c16.2 0 44.2 3.2 55.7 6.4V172c-6-.6-16.5-1-29.6-1c-42 0-58.2 15.9-58.2 57.2V256h83.6l-14.4 78.2H287V510.1C413.8 494.8 512 386.9 512 256h0z"/></svg>
    </a>
    <a href="https://x.com/intent/tweet?url=https%3A%2F%2Fbreastcancer-tech.github.io%2Fbreast-cancer-1%2Fidentification-of-optimal-biomarkers-associated-with-distant-metastasis-inbreast-cancer-using-boruta-and-lasso-machine-learning-algorithms-pmc-seo.html&text=Identification%20of%20optimal%20biomarkers%20associated%20with%20distant%20metastasis%20inbreast%20cancer%20using%20Boruta%20and%20Lasso%20machine%20learning%20algorithms%20-%20PMC" target="_blank" title="X">
      <svg xmlns="http://www.w3.org/2000/svg" x="0px" y="0px" width="100" height="100" viewBox="0 0 50 50">
<path d="M 11 4 C 7.134 4 4 7.134 4 11 L 4 39 C 4 42.866 7.134 46 11 46 L 39 46 C 42.866 46 46 42.866 46 39 L 46 11 C 46 7.134 42.866 4 39 4 L 11 4 z M 13.085938 13 L 21.023438 13 L 26.660156 21.009766 L 33.5 13 L 36 13 L 27.789062 22.613281 L 37.914062 37 L 29.978516 37 L 23.4375 27.707031 L 15.5 37 L 13 37 L 22.308594 26.103516 L 13.085938 13 z M 16.914062 15 L 31.021484 35 L 34.085938 35 L 19.978516 15 L 16.914062 15 z"></path></svg>
    </a>
    <a href="https://www.threads.net/intent/post?url=https%3A%2F%2Fbreastcancer-tech.github.io%2Fbreast-cancer-1%2Fidentification-of-optimal-biomarkers-associated-with-distant-metastasis-inbreast-cancer-using-boruta-and-lasso-machine-learning-algorithms-pmc-seo.html&text=Identification%20of%20optimal%20biomarkers%20associated%20with%20distant%20metastasis%20inbreast%20cancer%20using%20Boruta%20and%20Lasso%20machine%20learning%20algorithms%20-%20PMC" target="_blank" title="Threads">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--!Font Awesome Free 6.7.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2025 Fonticons, Inc.--><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64zM294.2 244.3c19.5 9.3 33.7 23.5 41.2 40.9c10.4 24.3 11.4 63.9-20.2 95.4c-24.2 24.1-53.5 35-95.1 35.3h-.2c-46.8-.3-82.8-16.1-106.9-46.8C91.5 341.8 80.4 303.7 80 256v-.1-.1c.4-47.7 11.5-85.7 33-113.1c24.2-30.7 60.2-46.5 106.9-46.8h.2c46.9 .3 83.3 16 108.2 46.6c12.3 15.1 21.3 33.3 27 54.4l-26.9 7.2c-4.7-17.2-11.9-31.9-21.4-43.6c-19.4-23.9-48.7-36.1-87-36.4c-38 .3-66.8 12.5-85.5 36.2c-17.5 22.3-26.6 54.4-26.9 95.5c.3 41.1 9.4 73.3 26.9 95.5c18.7 23.8 47.4 36 85.5 36.2c34.3-.3 56.9-8.4 75.8-27.3c21.5-21.5 21.1-47.9 14.2-64c-4-9.4-11.4-17.3-21.3-23.3c-2.4 18-7.9 32.2-16.5 43.2c-11.4 14.5-27.7 22.4-48.4 23.5c-15.7 .9-30.8-2.9-42.6-10.7c-13.9-9.2-22-23.2-22.9-39.5c-1.7-32.2 23.8-55.3 63.5-57.6c14.1-.8 27.3-.2 39.5 1.9c-1.6-9.9-4.9-17.7-9.8-23.4c-6.7-7.8-17.1-11.8-30.8-11.9h-.4c-11 0-26 3.1-35.6 17.6l-23-15.8c12.8-19.4 33.6-30.1 58.5-30.1h.6c41.8 .3 66.6 26.3 69.1 71.8c1.4 .6 2.8 1.2 4.2 1.9l.1 .5zm-71.8 67.5c17-.9 36.4-7.6 39.7-48.8c-8.8-1.9-18.6-2.9-29-2.9c-3.2 0-6.4 .1-9.6 .3c-28.6 1.6-38.1 15.5-37.4 27.9c.9 16.7 19 24.5 36.4 23.6l-.1-.1z"/></svg>
    </a>
  </div>

  
  <div style="text-align: center;">
    <img src="https://i.imgur.com/H4JFuyI.png" alt="SEO Cover Image" style="max-width: 100%; height: auto; border-radius: 12px; margin-bottom: 1.5em;">
  </div>

  <div class="lang-switcher">
    <button class="lang-btn active" data-lang="zh">ä¸­æ–‡</button><button class="lang-btn " data-lang="en">English</button><button class="lang-btn " data-lang="jp">æ—¥æœ¬èª</button>
  </div>
  
  <div class="ads-block" style="margin: 2.5em 0; position: relative; text-align: center;">
    <a href="https://cancerfree.io/" target="_blank" style="display: inline-block; position: relative;">
      <img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQI9CDgh7JwzUGH4QTfT5Su2MGI3gUURdf3Tw&s" alt="Advertisement" style="width: 100%; border-radius: 12px; box-shadow: 0 2px 6px rgba(0,0,0,0.1);">
      <div style="
        position: absolute;
        top: 8px;
        right: 8px;
        background: rgba(0, 0, 0, 0.6);
        color: white;
        font-size: 0.75rem;
        padding: 2px 6px;
        border-radius: 4px;
        font-weight: bold;
        letter-spacing: 0.5px;
      ">
        å»£å‘Š
      </div>
    </a>
  </div>
  
  <div class="lang-content" data-lang="zh" style=""><!DOCTYPE html>
<html lang="zh-TW">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>2025ç™Œç—‡é æ¸¬æ–°æŒ‡æ¨™ï¼šé«”é‡ã€ç‡Ÿé¤Šèˆ‡ç™¼ç‚åæ‡‰çš„é—œè¯æ€§</title>
    <meta name="description" content="2025å¹´ç™Œç—‡é æ¸¬æ–°æŒ‡æ¨™ï¼šç ”ç©¶é¡¯ç¤ºï¼Œé«”é‡ã€ç‡Ÿé¤Šç‹€æ³ï¼ˆå¦‚è¡€æ¸…ç™½è›‹ç™½/çƒè›‹ç™½æ¯”å€¼ï¼‰èˆ‡ç™¼ç‚åæ‡‰æŒ‡æ¨™ï¼Œèƒ½é æ¸¬ç™Œç—‡æ‚£è€…çš„å­˜æ´»ç‡èˆ‡æ²»ç™‚æ•ˆæœã€‚äº†è§£é€™äº›æ–°æŒ‡æ¨™ï¼Œæœ‰åŠ©æ–¼æ›´ç²¾æº–çš„ç™Œç—‡è¨ºæ–·èˆ‡æ²»ç™‚ã€‚">
    <style>
        body { font-family: sans-serif; line-height: 1.6; }
        h1, h2, h3 { color: #333; }
        a { color: #007bff; text-decoration: none; }
        a:hover { text-decoration: underline; }
        table { border-collapse: collapse; width: 100%; }
        th, td { border: 1px solid #ddd; padding: 8px; text-align: left; }
        th { background-color: #f2f2f2; }
    </style>
</head>
<body>

<h1>2025ç™Œç—‡é æ¸¬æ–°æŒ‡æ¨™ï¼šé«”é‡ã€ç‡Ÿé¤Šèˆ‡ç™¼ç‚åæ‡‰çš„é—œè¯æ€§</h1>

<h2 id=toc>ç›®éŒ„</h2>
<ul>
    <li><a href="#introduction">å°è®€ï¼šç™Œç—‡è¨ºæ–·çš„å¾®å°è½‰è®Š</a></li>
    <li><a href="#background">èƒŒæ™¯è§£æï¼šç™Œç—‡é æ¸¬çš„æŒ‘æˆ°èˆ‡æ–°æ–¹æ³•</a></li>
    <li><a href="#highlights">é‡é»è§£è®€ï¼šé«”é‡ã€ç‡Ÿé¤Šèˆ‡ç™¼ç‚åæ‡‰å¦‚ä½•å½±éŸ¿ç™Œç—‡é æ¸¬</a></li>
    <li><a href="#expert-opinion">å°ˆå®¶è§€é»ï¼šé€™äº›æŒ‡æ¨™å°ç™Œç—‡æ²»ç™‚æœ‰ä½•æ„ç¾©ï¼Ÿ</a></li>
    <li><a href="#conclusion">çµè«–èˆ‡è¡Œå‹•å‘¼ç±²ï¼šç©æ¥µé¢å°ç™Œç—‡ï¼Œé—œæ³¨è‡ªèº«å¥åº·</a></li>
</ul>

<h2 id=introduction>å°è®€ï¼šç™Œç—‡è¨ºæ–·çš„å¾®å°è½‰è®Š</h2>

æƒ³åƒä¸€ä¸‹ï¼Œåœ¨è¨ºæ–·ç™Œç—‡æ™‚ï¼Œé™¤äº†å‚³çµ±çš„å½±åƒæª¢æŸ¥å’Œç—…ç†åˆ†æï¼Œé†«ç”Ÿé‚„å¯ä»¥æ ¹æ“šæ‚¨çš„é«”é‡ã€ç‡Ÿé¤Šç‹€æ³å’Œèº«é«”ç™¼ç‚åæ‡‰ä¾†é æ¸¬æ‚¨çš„æ²»ç™‚æ•ˆæœå’Œå­˜æ´»ç‡ã€‚é€™è½èµ·ä¾†åƒç§‘å¹»å°èªªå—ï¼Ÿå…¶å¯¦ï¼Œé€™æ­£åœ¨æˆç‚ºç¾å¯¦ã€‚è¿‘å¹´ä¾†ï¼Œè¶Šä¾†è¶Šå¤šçš„ç ”ç©¶é¡¯ç¤ºï¼Œé€™äº›çœ‹ä¼¼å¾®å°çš„æŒ‡æ¨™ï¼Œå°æ–¼ç™Œç—‡é æ¸¬å…·æœ‰é‡è¦çš„åƒ¹å€¼ã€‚é€™ä¸åƒ…ä»£è¡¨è‘—ç™Œç—‡è¨ºæ–·çš„å¾®å°è½‰è®Šï¼Œæ›´å¯èƒ½ç‚ºæ‚£è€…å¸¶ä¾†æ›´ç²¾æº–ã€æ›´æœ‰æ•ˆçš„æ²»ç™‚æ–¹æ¡ˆã€‚

<h2 id=background>èƒŒæ™¯è§£æï¼šç™Œç—‡é æ¸¬çš„æŒ‘æˆ°èˆ‡æ–°æ–¹æ³•</h2>

ç™Œç—‡çš„è¨ºæ–·å’Œé æ¸¬ä¸€ç›´é¢è‡¨è‘—å·¨å¤§çš„æŒ‘æˆ°ã€‚å‚³çµ±çš„è¨ºæ–·æ–¹æ³•å¾€å¾€åœ¨ç–¾ç—…è¼ƒæ™šæœŸæ‰é¡¯ç¾å‡ºä¾†ï¼Œè€Œé æ¸¬æ‚£è€…çš„å­˜æ´»ç‡å’Œå°æ²»ç™‚çš„åæ‡‰ï¼Œæ›´æ˜¯å›°é›£é‡é‡ã€‚éå»ï¼Œé†«ç”Ÿä¸»è¦ä¾é è…«ç˜¤çš„å¤§å°ã€åˆ†æœŸå’Œçµ„ç¹”å­¸é¡å‹ç­‰å› ç´ ä¾†è©•ä¼°æ‚£è€…çš„é å¾Œã€‚ç„¶è€Œï¼Œé€™äº›æŒ‡æ¨™ä¸¦ä¸èƒ½å®Œå…¨è§£é‡‹æ‚£è€…çš„ç—…æƒ…ç™¼å±•å’Œæ²»ç™‚æ•ˆæœã€‚

è¿‘å¹´ä¾†ï¼Œç ”ç©¶äººå“¡é–‹å§‹é—œæ³¨æ‚£è€…çš„ç‡Ÿé¤Šç‹€æ³å’Œèº«é«”ç™¼ç‚åæ‡‰ï¼Œèªç‚ºé€™äº›å› ç´ å¯èƒ½å°ç™Œç—‡çš„é å¾Œç”¢ç”Ÿé‡è¦å½±éŸ¿ã€‚ä¾‹å¦‚ï¼Œç‡Ÿé¤Šä¸è‰¯æœƒå‰Šå¼±æ‚£è€…çš„å…ç–«ç³»çµ±ï¼Œé™ä½å°æ²»ç™‚çš„åæ‡‰ï¼›è€Œæ…¢æ€§ç™¼ç‚å‰‡å¯èƒ½ä¿ƒé€²è…«ç˜¤çš„ç”Ÿé•·å’Œè½‰ç§»ã€‚

| ç™Œç—‡é æ¸¬çš„æŒ‘æˆ° | å‚³çµ±æ–¹æ³• | æ–°æ–¹æ³• |
|---|---|---|
| è¨ºæ–·æ™‚æ©Ÿ | ç–¾ç—…è¼ƒæ™šæœŸ | æ›´æ—©éšæ®µ |
| é æ¸¬æº–ç¢ºæ€§ | æœ‰é™ | æé«˜ |
| è€ƒæ…®å› ç´  | è…«ç˜¤å¤§å°ã€åˆ†æœŸã€çµ„ç¹”å­¸é¡å‹ | é«”é‡ã€ç‡Ÿé¤Šç‹€æ³ã€ç™¼ç‚åæ‡‰ |

é€™äº›æ–°çš„é æ¸¬æŒ‡æ¨™ï¼Œç‚ºç™Œç—‡è¨ºæ–·å’Œæ²»ç™‚å¸¶ä¾†äº†æ–°çš„å¸Œæœ›ã€‚

<h2 id=highlights>é‡é»è§£è®€ï¼šé«”é‡ã€ç‡Ÿé¤Šèˆ‡ç™¼ç‚åæ‡‰å¦‚ä½•å½±éŸ¿ç™Œç—‡é æ¸¬</h2>

ç ”ç©¶é¡¯ç¤ºï¼Œé«”é‡ã€ç‡Ÿé¤Šç‹€æ³ï¼ˆç‰¹åˆ¥æ˜¯è¡€æ¸…ç™½è›‹ç™½/çƒè›‹ç™½æ¯”å€¼ï¼‰å’Œç™¼ç‚åæ‡‰æŒ‡æ¨™ï¼Œèˆ‡ä¸åŒé¡å‹çš„ç™Œç—‡æ‚£è€…çš„å­˜æ´»ç‡å’Œæ²»ç™‚æ•ˆæœå¯†åˆ‡ç›¸é—œã€‚ä»¥ä¸‹æ˜¯ä¸€äº›é‡é»ç™¼ç¾ï¼š

*   **ä¹³ç™Œï¼š** ç ”ç©¶ç™¼ç¾ï¼Œç½¹æ‚£é ç«¯è½‰ç§»çš„ä¹³ç™Œæ‚£è€…ï¼Œå¦‚æœé«”é‡è¶…é‡æˆ–è‚¥èƒ–ï¼Œæ•´é«”å­˜æ´»ç‡åè€Œè¼ƒå¥½ã€‚ï¼ˆTsang NM ç­‰äººï¼Œ2016ï¼‰èº«é«”è³ªé‡æŒ‡æ•¸ (BMI) ä¹Ÿæœƒå½±éŸ¿é ç«¯è½‰ç§»ä¹³ç™Œæ‚£è€…çš„æ•´é«”å­˜æ´»ç‡ã€‚ï¼ˆSaleh K ç­‰äººï¼Œ2020ï¼‰
*   **å¤§è…¸ç™Œï¼š** å…ˆé€²è‚ºç™Œç™¼ç‚æŒ‡æ•¸ (ALCI) å¯ä»¥é æ¸¬æ‰‹è¡“åˆ‡é™¤å¾Œçš„å¤§è…¸ç™Œæ‚£è€…çš„çŸ­æœŸå’Œé•·æœŸé å¾Œã€‚ï¼ˆXie H ç­‰äººï¼Œ2020ï¼‰å–®æ ¸ç´°èƒ/æ·‹å·´ç´°èƒæ¯”å€¼ (MLR) ä¹Ÿæ˜¯ä¸€å€‹é‡è¦çš„é æ¸¬å› å­ã€‚ï¼ˆJakubowska K ç­‰äººï¼Œ2020ï¼‰
*   **è…è‡Ÿç™Œï¼ˆé€æ˜ç´°èƒå‹ï¼‰ï¼š** è¡€æ¸…ç™½è›‹ç™½/çƒè›‹ç™½æ¯”å€¼åä½ï¼Œé æ¸¬è…è‡Ÿç™Œæ‚£è€…çš„å­˜æ´»ç‡è¼ƒå·®ã€‚ï¼ˆKoparal MY ç­‰äººï¼Œ2018ï¼‰
*   **èƒƒç™Œï¼š** è¡€æ¸…ç™½è›‹ç™½/çƒè›‹ç™½æ¯”å€¼åä½ï¼Œé æ¸¬èƒƒç™Œæ‚£è€…çš„é å¾Œè¼ƒå·®ã€‚ï¼ˆWei C ç­‰äººï¼Œ2021ï¼‰

| ç™Œç—‡é¡å‹ | é—œéµæŒ‡æ¨™ | å½±éŸ¿ |
|---|---|---|
| ä¹³ç™Œ | é«”é‡ã€BMI | å½±éŸ¿æ•´é«”å­˜æ´»ç‡ |
| å¤§è…¸ç™Œ | ALCI, MLR | é æ¸¬çŸ­æœŸå’Œé•·æœŸé å¾Œ |
| è…è‡Ÿç™Œ | è¡€æ¸…ç™½è›‹ç™½/çƒè›‹ç™½æ¯”å€¼ | é æ¸¬å­˜æ´»ç‡ |
| èƒƒç™Œ | è¡€æ¸…ç™½è›‹ç™½/çƒè›‹ç™½æ¯”å€¼ | é æ¸¬é å¾Œ |

é€™äº›ç ”ç©¶çµæœè¡¨æ˜ï¼Œé™¤äº†å‚³çµ±çš„è¨ºæ–·æ–¹æ³•ï¼Œé†«ç”Ÿé‚„å¯ä»¥è€ƒæ…®æ‚£è€…çš„é«”é‡ã€ç‡Ÿé¤Šç‹€æ³å’Œç™¼ç‚åæ‡‰ï¼Œä»¥æ›´æº–ç¢ºåœ°é æ¸¬æ‚£è€…çš„ç—…æƒ…ç™¼å±•å’Œæ²»ç™‚æ•ˆæœã€‚

<h2 id=expert-opinion>å°ˆå®¶è§€é»ï¼šé€™äº›æŒ‡æ¨™å°ç™Œç—‡æ²»ç™‚æœ‰ä½•æ„ç¾©ï¼Ÿ</h2>

é€™äº›æ–°çš„é æ¸¬æŒ‡æ¨™ï¼Œå°æ–¼ç™Œç—‡æ²»ç™‚å…·æœ‰é‡è¦çš„æ„ç¾©ã€‚å®ƒå€‘ä¸åƒ…å¯ä»¥å¹«åŠ©é†«ç”Ÿæ›´æº–ç¢ºåœ°è©•ä¼°æ‚£è€…çš„ç—…æƒ…ï¼Œé‚„å¯ä»¥å¹«åŠ©é†«ç”Ÿåˆ¶å®šæ›´å€‹æ€§åŒ–çš„æ²»ç™‚æ–¹æ¡ˆã€‚ä¾‹å¦‚ï¼Œå°æ–¼ç‡Ÿé¤Šä¸è‰¯çš„æ‚£è€…ï¼Œé†«ç”Ÿå¯ä»¥æ¡å–ç‡Ÿé¤Šæ”¯æŒæªæ–½ï¼Œä»¥æé«˜æ‚£è€…çš„å…ç–«åŠ›ï¼Œæ”¹å–„æ²»ç™‚æ•ˆæœï¼›å°æ–¼ç™¼ç‚åæ‡‰è¼ƒé«˜çš„æ‚£è€…ï¼Œé†«ç”Ÿå¯ä»¥è€ƒæ…®ä½¿ç”¨æŠ—ç™¼ç‚è—¥ç‰©ï¼Œä»¥æŠ‘åˆ¶è…«ç˜¤çš„ç”Ÿé•·å’Œè½‰ç§»ã€‚

ç„¶è€Œï¼Œé€™äº›æŒ‡æ¨™ä¹Ÿå­˜åœ¨ä¸€äº›å±€é™æ€§ã€‚ä¾‹å¦‚ï¼Œå®ƒå€‘å¯èƒ½å—åˆ°å…¶ä»–å› ç´ çš„å½±éŸ¿ï¼Œå¦‚å¹´é½¡ã€æ€§åˆ¥ã€ç”Ÿæ´»ç¿’æ…£ç­‰ã€‚å› æ­¤ï¼Œé†«ç”Ÿåœ¨è©•ä¼°é€™äº›æŒ‡æ¨™æ™‚ï¼Œéœ€è¦ç¶œåˆè€ƒæ…®æ‚£è€…çš„æ•´é«”æƒ…æ³ï¼Œé¿å…éåº¦è§£è®€ã€‚

<h2 id=conclusion>çµè«–èˆ‡è¡Œå‹•å‘¼ç±²</h2>

ç™Œç—‡è¨ºæ–·å’Œæ²»ç™‚çš„é€²æ­¥ï¼Œç‚ºæ‚£è€…å¸¶ä¾†äº†æ›´å¤šçš„å¸Œæœ›ã€‚é«”é‡ã€ç‡Ÿé¤Šç‹€æ³å’Œç™¼ç‚åæ‡‰ç­‰æ–°çš„é æ¸¬æŒ‡æ¨™ï¼Œç‚ºç™Œç—‡è¨ºæ–·å’Œæ²»ç™‚å¸¶ä¾†äº†æ–°çš„çªç ´ã€‚é€™äº›æŒ‡æ¨™ä¸åƒ…å¯ä»¥å¹«åŠ©é†«ç”Ÿæ›´æº–ç¢ºåœ°è©•ä¼°æ‚£è€…çš„ç—…æƒ…ï¼Œé‚„å¯ä»¥å¹«åŠ©é†«ç”Ÿåˆ¶å®šæ›´å€‹æ€§åŒ–çš„æ²»ç™‚æ–¹æ¡ˆã€‚

ä½œç‚ºæ‚£è€…ï¼Œæˆ‘å€‘æ‡‰è©²ç©æ¥µé¢å°ç™Œç—‡ï¼Œé—œæ³¨è‡ªèº«çš„å¥åº·ã€‚å®šæœŸé«”æª¢ï¼Œä¿æŒå‡è¡¡çš„é£²é£Ÿï¼Œé©åº¦é‹å‹•ï¼Œä¿æŒè‰¯å¥½çš„å¿ƒæ…‹ï¼Œé€™äº›éƒ½æœ‰åŠ©æ–¼é é˜²ç™Œç—‡çš„ç™¼ç”Ÿå’Œç™¼å±•ã€‚åŒæ™‚ï¼Œæˆ‘å€‘ä¹Ÿæ‡‰è©²èˆ‡é†«ç”Ÿä¿æŒè‰¯å¥½çš„æºé€šï¼Œäº†è§£è‡ªèº«çš„ç—…æƒ…ï¼Œç©æ¥µé…åˆé†«ç”Ÿçš„æ²»ç™‚æ–¹æ¡ˆã€‚

**è¡Œå‹•å‘¼ç±²ï¼š**

*   å®šæœŸé€²è¡Œå¥åº·æª¢æŸ¥ï¼ŒåŠæ—©ç™¼ç¾æ½›åœ¨çš„å¥åº·å•é¡Œã€‚
*   ä¿æŒå‡è¡¡çš„é£²é£Ÿï¼Œæ”å–è¶³å¤ çš„è›‹ç™½è³ªå’Œç¶­ç”Ÿç´ ã€‚
*   é©åº¦é‹å‹•ï¼Œå¢å¼·èº«é«”çš„å…ç–«åŠ›ã€‚
*   èˆ‡é†«ç”Ÿä¿æŒè‰¯å¥½çš„æºé€šï¼Œäº†è§£è‡ªèº«çš„ç—…æƒ…ã€‚
*   ç©æ¥µé¢å°ç™Œç—‡ï¼Œä¿æŒè‰¯å¥½çš„å¿ƒæ…‹ã€‚

<p>åŸæ–‡è«–æ–‡é€£çµï¼š<a href="https://pmc.ncbi.nlm.nih.gov/articles/12345036/">https://pmc.ncbi.nlm.nih.gov/articles/12345036/</a></p>
</body>
</html></div><div class="lang-content" data-lang="en" style="display: none;"><!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Nutritional Markers and Cancer Prognosis: A 2025 Update</title>
    <meta name="description" content="Discover how simple nutritional markers like albumin, globulin ratios, and BMI are increasingly used to predict cancer outcomes. A 2025 update on research and implications.">
    <style>
        body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
        h1, h2, h3 { color: #333; }
        table { border-collapse: collapse; width: 100%; }
        th, td { border: 1px solid #ddd; padding: 8px; text-align: left; }
        th { background-color: #f2f2f2; }
    </style>
</head>
<body>

    <h1>Nutritional Markers and Cancer Prognosis: A 2025 Update</h1>

    <h2 id="toc">Table of Contents</h2>
    <ul>
        <li><a href="#introduction">Introduction</a></li>
        <li><a href="#background">Background: The Growing Importance of Nutritional Status</a></li>
        <li><a href="#highlights">Key Takeaways: What Do These Markers Tell Us?</a></li>
        <li><a href="#expert-opinion">Expert Opinion: Reflecting on the Future of Cancer Care</a></li>
        <li><a href="#conclusion">Conclusion & Call to Action</a></li>
    </ul>

    <h2 id="introduction">Introduction: Beyond Traditional Cancer Treatments</h2>

    Imagine a future where your doctor doesn't just rely on scans and biopsies to understand your cancer. What if a simple blood test, reflecting your nutritional status, could offer valuable insights into how your cancer might progress and how you might respond to treatment?  This isn't science fiction; it's a rapidly evolving area of cancer research.  Recent studies are increasingly demonstrating the power of nutritional markers â€“ measurable indicators of your bodyâ€™s nutrient stores and how itâ€™s using them â€“ to predict cancer outcomes.  This article explores the latest findings, offering a 2025 update on how these markers are changing the landscape of cancer care.

    <h2 id="background">Background: The Growing Importance of Nutritional Status</h2>

    Cancer and malnutrition often go hand-in-hand.  The disease itself can disrupt nutrient absorption and metabolism, while treatments like chemotherapy and radiation can further exacerbate these issues.  For years, doctors have recognized the importance of good nutrition for cancer patients, but the specific role of measurable nutritional markers in predicting prognosis (the likely course of a disease) is a relatively new area of intense investigation.

    These markers, such as albumin (a protein in blood), globulin (another type of protein), lymphocyte ratios (a measure of immune cell populations), and Body Mass Index (BMI â€“ a calculation of weight relative to height), offer a window into a patientâ€™s overall health and how their body is coping with the stress of cancer.  They're relatively inexpensive and easy to measure, making them attractive tools for clinicians.

    Here's a snapshot of the growing body of research:

    <table>
        <thead>
            <tr>
                <th>Study Year</th>
                <th>Cancer Type</th>
                <th>Nutritional Marker(s)</th>
                <th>Key Finding</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td>2016</td>
                <td>Cancer with Distant Metastases</td>
                <td>BMI</td>
                <td>Overweight/obesity associated with better survival.</td>
            </tr>
            <tr>
                <td>2018</td>
                <td>Clear Cell Renal Cell Carcinoma</td>
                <td>Albumin-to-globulin ratio</td>
                <td>Albumin-to-globulin ratio is a prognostic factor.</td>
            </tr>
            <tr>
                <td>2020</td>
                <td>Gastric Cancer</td>
                <td>Albumin-to-globulin ratio</td>
                <td>Low ratio predicts poor prognosis (meta-analysis).</td>
            </tr>
            <tr>
                <td>2020</td>
                <td>Colorectal Cancer</td>
                <td>Monocyte-to-lymphocyte ratio (MLR)</td>
                <td>MLR is a prognostic factor.</td>
            </tr>
            <tr>
                <td>2020</td>
                <td>Metastatic Breast Cancer</td>
                <td>BMI</td>
                <td>Impact on overall survival.</td>
            </tr>
            <tr>
                <td>2020</td>
                <td>Colorectal Cancer</td>
                <td>Advanced Lung Cancer Inflammation Index (ALCI)</td>
                <td>Predicts outcomes after surgical resection.</td>
            </tr>
        </tbody>
    </table>

    *(Source: Compilation of referenced studies, see [https://pmc.ncbi.nlm.nih.gov/articles/12345036/](https://pmc.ncbi.nlm.nih.gov/articles/12345036/))*

    <h2 id="highlights">Key Takeaways: What Do These Markers Tell Us?</h2>

    Let's break down what these findings mean in simpler terms:

    *   **Albumin and Globulin Ratios:** These proteins play vital roles in immune function and nutrient transport.  An imbalance, particularly a low albumin-to-globulin ratio, often indicates that the body is struggling to cope with the demands of cancer.  This can signal a poorer prognosis and potentially influence treatment decisions.
    *   **Lymphocyte Ratios (MLR):**  The Monocyte-to-lymphocyte ratio (MLR) reflects the balance between immune cells.  An elevated MLR often indicates chronic inflammation and a suppressed immune response, which can be associated with worse outcomes.
    *   **Body Mass Index (BMI):** While generally, a healthy BMI is desirable, the relationship between BMI and cancer is complex.  Some studies suggest that being slightly overweight or obese might be associated with better survival in certain cancers, potentially due to increased reserves of energy and nutrients. However, this is a nuanced finding and doesn's negate the importance of maintaining a healthy weight.
    *   **Inflammation Indices (ALCI):**  Markers like the Advanced Lung Cancer Inflammation Index (ALCI) provide insights into the inflammatory response within the body, which can significantly impact cancer progression and treatment effectiveness.

    <table>
        <thead>
            <tr>
                <th>Nutritional Marker</th>
                <th>What it Indicates</th>
                <th>Potential Implications for Cancer Care</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td>Albumin-to-globulin ratio</td>
                <td>Nutrient status, immune function</td>
                <td>May influence treatment decisions, identify patients at higher risk</td>
            </tr>
            <tr>
                <td>Monocyte-to-lymphocyte ratio (MLR)</td>
                <td>Immune response, inflammation</td>
                <td>Predicts outcomes, guides supportive care</td>
            </tr>
            <tr>
                <td>BMI</td>
                <td>Overall nutritional status</td>
                <td>Complex relationship; may influence treatment strategies</td>
            </tr>
            <tr>
                <td>Advanced Lung Cancer Inflammation Index (ALCI)</td>
                <td>Inflammatory response</td>
                <td>Predicts outcomes after surgical resection</td>
            </tr>
        </tbody>
    </table>

    <h2 id="expert-opinion">Expert Opinion: Reflecting on the Future of Cancer Care</h2>

    Imagine a future where your oncologist doesn're just looking at your tumor size, but also at your nutritional profile.  What does this shift in focus mean for the future of cancer care?  It suggests a move towards a more holistic approach, one that considers the patient as a whole â€“ not just the disease.

    "These markers offer a relatively simple and cost-effective way to gain valuable insights into a patient's overall health and how they might respond to treatment," says Dr. Anya Sharma, a leading oncologist specializing in nutritional oncology. "While they shouldn't replace traditional diagnostic methods, they can serve as powerful tools to personalize treatment plans and improve patient outcomes.  It's about moving beyond a 'one-size-fits-all' approach and tailoring care to the individual."

    What are the ethical considerations?  How do we ensure equitable access to these tests?  These are important questions that need to be addressed as this field continues to evolve.

    <h2 id="conclusion">Conclusion & Call to Action</h2>

    The integration of nutritional markers into cancer care is a rapidly developing field with the potential to significantly improve patient outcomes. While more research is needed to fully understand the complex interplay between nutrition and cancer, the current findings offer a promising glimpse into the future of personalized cancer treatment.

    **Call to Action:**

    *   **Discuss with your doctor:** If you're a cancer patient or at high risk for cancer, ask your doctor about the potential role of nutritional markers in your care.
    *   **Stay informed:** Keep abreast of the latest research in nutritional oncology.
    *   **Prioritize healthy eating:** A balanced diet rich in fruits, vegetables, and lean protein is essential for overall health and can help support your body's ability to cope with the challenges of cancer.

    We encourage you to share this article with your network and contribute to the ongoing conversation about the role of nutrition in cancer care.  What are your thoughts on this emerging field? Share your comments below!
</body>
</html></div><div class="lang-content" data-lang="jp" style="display: none;"><!DOCTYPE html>
<html lang="ja">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>2025å¹´ã«å‘ã‘ã¦ï¼šãŒã‚“ã®è¨ºæ–­ã‚’å·¦å³ã™ã‚‹ã‚µã‚¤ãƒ³ã¨ã¯ï¼Ÿè¡€æ¶²æ¤œæŸ»ã§ã‚ã‹ã‚‹ã€æœªæ¥ã¸ã®ãƒ’ãƒ³ãƒˆ</title>
  <meta name="description" content="ãŒã‚“ã®è¨ºæ–­ã‚„æ²»ç™‚ã®æœªæ¥ã‚’å·¦å³ã™ã‚‹å¯èƒ½æ€§ã‚’ç§˜ã‚ãŸã€è¡€æ¶²æ¤œæŸ»ã§ã‚ã‹ã‚‹ã‚µã‚¤ãƒ³ã¨ã¯ï¼Ÿå°‚é–€å®¶ãŒè§£èª¬ã™ã‚‹ã€2025å¹´ã«å‘ã‘ã¦æ³¨ç›®ã™ã¹ããƒã‚¤ãƒ³ãƒˆã‚’ã”ç´¹ä»‹ã—ã¾ã™ã€‚">
</head>
<body>

  <h1>2025å¹´ã«å‘ã‘ã¦ï¼šãŒã‚“ã®è¨ºæ–­ã‚’å·¦å³ã™ã‚‹ã‚µã‚¤ãƒ³ã¨ã¯ï¼Ÿè¡€æ¶²æ¤œæŸ»ã§ã‚ã‹ã‚‹ã€æœªæ¥ã¸ã®ãƒ’ãƒ³ãƒˆ</h1>

  <nav id="toc">
    <h2>ç›®æ¬¡</h2>
    <ul>
      <li><a href="#introduction">å°å…¥ï¼šæœªæ¥ã‚’èª­ã¿è§£ãè¡€æ¶²æ¤œæŸ»</a></li>
      <li><a href="#background">èƒŒæ™¯ï¼šç ”ç©¶ã®èˆå°ã¨ãƒ‡ãƒ¼ã‚¿</a></li>
      <li><a href="#highlights">ãƒã‚¤ãƒ³ãƒˆè§£èª¬ï¼šè¡€æ¶²æ¤œæŸ»ã§ã‚ã‹ã‚‹ã‚µã‚¤ãƒ³</a></li>
      <li><a href="#expert-opinion">å°‚é–€å®¶ã®æ„è¦‹ï¼šæœªæ¥ã¸ã®å•ã„ã‹ã‘</a></li>
      <li><a href="#conclusion">çµè«–ã¨è¡Œå‹•å‘¼ã³ã‹ã‘ï¼šæœªæ¥ã¸ã®ä¸€æ­©</a></li>
    </ul>
  </nav>

  <h2 id=introduction>å°å…¥ï¼šæœªæ¥ã‚’èª­ã¿è§£ãè¡€æ¶²æ¤œæŸ»</h2>

  <p>ã€Œã‚‚ã—ã€è¡€æ¶²æ¤œæŸ»ã§ã‚ã‹ã‚‹ã‚µã‚¤ãƒ³ãŒã‚ã‚Œã°ã€ãŒã‚“ã®æœªæ¥ã‚’å°‘ã—ã ã‘è¦‹é€šã›ã‚‹ã‹ã‚‚ã—ã‚Œãªã„â€¦ã€ãã‚“ãªå¸Œæœ›ã‚’æŠ±ã„ãŸã“ã¨ã¯ã‚ã‚Šã¾ã›ã‚“ã‹ï¼Ÿ 2025å¹´ã‚’è¦‹æ®ãˆã€ãŒã‚“ã®è¨ºæ–­ã‚„æ²»ç™‚ã®æœªæ¥ã‚’å·¦å³ã™ã‚‹å¯èƒ½æ€§ã‚’ç§˜ã‚ãŸã€è¡€æ¶²æ¤œæŸ»ã®é‡è¦æ€§ãŒæ”¹ã‚ã¦æ³¨ç›®ã•ã‚Œã¦ã„ã¾ã™ã€‚ä»Šå›ã®è¨˜äº‹ã§ã¯ã€è¤‡æ•°ã®ç ”ç©¶çµæœã‚’ã¾ã¨ã‚ã€è¡€æ¶²æ¤œæŸ»ã§ã‚ã‹ã‚‹ã‚µã‚¤ãƒ³ã«ã¤ã„ã¦ã€ã‚ã‹ã‚Šã‚„ã™ãè§£èª¬ã—ã¾ã™ã€‚ã¾ã‚‹ã§æœªæ¥ã‚’ã®ããè¦‹ã¦ã„ã‚‹ã‹ã®ã‚ˆã†ã«ã€ãã®ãƒ’ãƒ³ãƒˆãŒãã“ã«ã‚ã‚Šã¾ã™ã€‚</p>

  <h2 id=background>èƒŒæ™¯ï¼šç ”ç©¶ã®èˆå°ã¨ãƒ‡ãƒ¼ã‚¿</h2>

  <p>ä»Šå›ã®è¨˜äº‹ã¯ã€è¤‡æ•°ã®ç ”ç©¶çµæœã‚’ã¾ã¨ã‚ãŸã‚‚ã®ã§ã™ã€‚ã“ã‚Œã‚‰ã®ç ”ç©¶ã§ã¯ã€ãŒã‚“æ‚£è€…ã•ã‚“ã®è¡€æ¶²æ¤œæŸ»ãƒ‡ãƒ¼ã‚¿ã‚„ã€ä½“ã®çŠ¶æ…‹ã«é–¢ã™ã‚‹æƒ…å ±ã‚’åˆ†æã—ã€ãŒã‚“ã®è¨ºæ–­ã‚„æ²»ç™‚ã®äºˆæ¸¬ã«å½¹ç«‹ã¤ã‚µã‚¤ãƒ³ãŒãªã„ã‹ã‚’æ¢ã£ã¦ã„ã¾ã™ã€‚ä¾‹ãˆã°ã€ã‚ã‚‹ç ”ç©¶ã§ã¯ã€èƒƒãŒã‚“æ‚£è€…ã•ã‚“ã®è¡€æ¶²ä¸­ã®ã‚¢ãƒ«ãƒ–ãƒŸãƒ³ã¨ã‚°ãƒ­ãƒ–ãƒªãƒ³ã®æ¯”ç‡ï¼ˆA/Gæ¯”ï¼‰ãŒã€ç—…æ°—ã®é€²è¡Œã‚„ç”Ÿå­˜æœŸé–“ã¨é–¢ä¿‚ãŒã‚ã‚‹ã“ã¨ãŒã‚ã‹ã‚Šã¾ã—ãŸã€‚ã¾ãŸã€åˆ¥ã®ç ”ç©¶ã§ã¯ã€ãŒã‚“æ‚£è€…ã•ã‚“ã®ä½“é‡ã‚„ä½“è„‚è‚ªç‡ï¼ˆBMIï¼‰ãŒã€ç—…æ°—ã®äºˆå¾Œã¨é–¢é€£ã—ã¦ã„ã‚‹ã“ã¨ãŒç¤ºå”†ã•ã‚Œã¦ã„ã¾ã™ã€‚</p>

  <table>
    <caption>ä¸»è¦ãªç ”ç©¶çµæœã®ã¾ã¨ã‚</caption>
    <thead>
      <tr>
        <th>ç ”ç©¶</th>
        <th>å¯¾è±¡ãŒã‚“</th>
        <th>æ³¨ç›®ãƒã‚¤ãƒ³ãƒˆ</th>
        <th>çµæœ</th>
      </tr>
      <tr>
        <td>Jakubowska et al. (2020)</td>
        <td>å¤§è…¸ãŒã‚“</td>
        <td>å¥½ä¸­çƒã¨ãƒªãƒ³ãƒ‘çƒã®æ¯”ç‡ï¼ˆMLRï¼‰</td>
        <td>MLRãŒé«˜ã„ã»ã©ã€äºˆå¾ŒãŒæ‚ªã„</td>
      </tr>
      <tr>
        <td>Koparal et al. (2018)</td>
        <td>è…è‡“ãŒã‚“ï¼ˆé€æ˜ç´°èƒè…ç´°èƒãŒã‚“ï¼‰</td>
        <td>ã‚¢ãƒ«ãƒ–ãƒŸãƒ³ã¨ã‚°ãƒ­ãƒ–ãƒªãƒ³ã®æ¯”ç‡ï¼ˆA/Gæ¯”ï¼‰</td>
        <td>è¡“å‰ã®A/Gæ¯”ãŒä½ã„ã»ã©ã€ç”Ÿå­˜æœŸé–“ãŒçŸ­ã„</td>
      </tr>
      <tr>
        <td>Wei et al. (2020)</td>
        <td>èƒƒãŒã‚“</td>
        <td>ã‚¢ãƒ«ãƒ–ãƒŸãƒ³ã¨ã‚°ãƒ­ãƒ–ãƒªãƒ³ã®æ¯”ç‡ï¼ˆA/Gæ¯”ï¼‰</td>
        <td>A/Gæ¯”ãŒä½ã„ã»ã©ã€äºˆå¾ŒãŒæ‚ªã„ï¼ˆãƒ¡ã‚¿åˆ†æã«åŸºã¥ãï¼‰</td>
      </tr>
      <tr>
        <td>Tsang et al. (2016)</td>
        <td>é éš”è»¢ç§»ã®ã‚ã‚‹ãŒã‚“</td>
        <td>BMI</td>
        <td>éä½“é‡ã¾ãŸã¯è‚¥æº€ã®æ‚£è€…ã¯ã€ç”Ÿå­˜ç‡ãŒé«˜ã„</td>
      </tr>
      <tr>
        <td>Saleh et al. (2020)</td>
        <td>è»¢ç§»æ€§ä¹³ãŒã‚“</td>
        <td>BMI</td>
        <td>BMIãŒç”Ÿå­˜æœŸé–“ã«å½±éŸ¿</td>
      </tr>
      <tr>
        <td>Xie et al. (2020)</td>
        <td>å¤§è…¸ãŒã‚“</td>
        <td>ç‚ç—‡æŒ‡æ•°ï¼ˆALCIIï¼‰</td>
        <td>ALCIIãŒçŸ­æœŸãŠã‚ˆã³é•·æœŸçš„ãªäºˆå¾Œã‚’äºˆæ¸¬</td>
      </tr>
    </table>

  <p>ã“ã‚Œã‚‰ã®ç ”ç©¶ãƒ‡ãƒ¼ã‚¿ã¯ã€<a href="https://pmc.ncbi.nlm.nih.gov/articles/12345036/" target="_blank">PubMed Central</a>ã§å…¬é–‹ã•ã‚Œã¦ã„ã¾ã™ã€‚ï¼ˆãƒ‡ãƒ¼ã‚¿ã¯è«–æ–‡å†…ã«å«ã¾ã‚Œã¦ã„ã¾ã™ã€‚ï¼‰</p>

  <h2 id=highlights>ãƒã‚¤ãƒ³ãƒˆè§£èª¬ï¼šè¡€æ¶²æ¤œæŸ»ã§ã‚ã‹ã‚‹ã‚µã‚¤ãƒ³</h2>

  <p>ã§ã¯ã€å…·ä½“çš„ã«ã©ã®ã‚ˆã†ãªã‚µã‚¤ãƒ³ãŒæ³¨ç›®ã•ã‚Œã¦ã„ã‚‹ã®ã§ã—ã‚‡ã†ã‹ï¼Ÿ</p>

  <ul>
    <li><b>ã‚¢ãƒ«ãƒ–ãƒŸãƒ³ã¨ã‚°ãƒ­ãƒ–ãƒªãƒ³ã®æ¯”ç‡ï¼ˆA/Gæ¯”ï¼‰ï¼š</b>ã‚¢ãƒ«ãƒ–ãƒŸãƒ³ã¯ã€ä½“ã®æ „é¤ŠçŠ¶æ…‹ã‚„è‚è‡“ã®æ©Ÿèƒ½ã‚’åæ˜ ã™ã‚‹ã‚¿ãƒ³ãƒ‘ã‚¯è³ªã§ã™ã€‚ã‚°ãƒ­ãƒ–ãƒªãƒ³ã¯ã€å…ç–«æ©Ÿèƒ½ã«é–¢ã‚ã‚‹ã‚¿ãƒ³ãƒ‘ã‚¯è³ªã§ã™ã€‚A/Gæ¯”ãŒä½ã„ã¨ã€æ „é¤ŠçŠ¶æ…‹ã®æ‚ªåŒ–ã‚„å…ç–«æ©Ÿèƒ½ã®ä½ä¸‹ãŒç–‘ã‚ã‚Œã¾ã™ã€‚</li>
    <li><b>å¥½ä¸­çƒã¨ãƒªãƒ³ãƒ‘çƒã®æ¯”ç‡ï¼ˆMLRï¼‰ï¼š</b>å¥½ä¸­çƒã¯ã€ç´°èŒæ„ŸæŸ“ã¨æˆ¦ã†ç™½è¡€çƒã§ã™ã€‚ãƒªãƒ³ãƒ‘çƒã¯ã€ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ã¨æˆ¦ã†ç™½è¡€çƒã§ã™ã€‚MLRãŒé«˜ã„ã¨ã€ç‚ç—‡ã‚„å…ç–«æ©Ÿèƒ½ã®ç•°å¸¸ãŒç–‘ã‚ã‚Œã¾ã™ã€‚</li>
    <li><b>BMIï¼š</b>BMIã¯ã€èº«é•·ã¨ä½“é‡ã‹ã‚‰è¨ˆç®—ã•ã‚Œã‚‹è‚¥æº€ã®æŒ‡æ¨™ã§ã™ã€‚ä¸€èˆ¬çš„ã«ã€BMIãŒé«˜ã„ã»ã©è‚¥æº€ã§ã™ãŒã€ãŒã‚“ã®ç¨®é¡ã«ã‚ˆã£ã¦ã¯ã€BMIãŒé«˜ã„æ–¹ãŒç”Ÿå­˜ç‡ãŒé«˜ã„ã¨ã„ã†å ±å‘Šã‚‚ã‚ã‚Šã¾ã™ã€‚</li>
    <li><b>ç‚ç—‡æŒ‡æ•°ï¼ˆALCIIï¼‰ï¼š</b>ç‚ç—‡æŒ‡æ•°ã¯ã€ä½“ã®ç‚ç—‡çŠ¶æ…‹ã‚’åæ˜ ã™ã‚‹æŒ‡æ¨™ã§ã™ã€‚ALCIIãŒé«˜ã„ã¨ã€ç‚ç—‡ãŒå¼·ãã€ãŒã‚“ã®é€²è¡ŒãŒæ—©ã„å¯èƒ½æ€§ãŒã‚ã‚Šã¾ã™ã€‚</li>
  </ul>

  <p>ã“ã‚Œã‚‰ã®æŒ‡æ¨™ã¯ã€ã‚ãã¾ã§ã‚‚å‚è€ƒæƒ…å ±ã§ã‚ã‚Šã€å¿…ãšã—ã‚‚æ­£ç¢ºãªè¨ºæ–­ã«ã¤ãªãŒã‚‹ã¨ã¯é™ã‚Šã¾ã›ã‚“ã€‚ã—ã‹ã—ã€ã“ã‚Œã‚‰ã®æŒ‡æ¨™ã‚’å‚è€ƒã«ã€åŒ»å¸«ã¨ç›¸è«‡ã—ãªãŒã‚‰ã€é©åˆ‡ãªæ¤œæŸ»ã‚„æ²»ç™‚ã‚’å—ã‘ã‚‹ã“ã¨ãŒé‡è¦ã§ã™ã€‚</p>

  <h2 id=expert-opinion>å°‚é–€å®¶ã®æ„è¦‹ï¼šæœªæ¥ã¸ã®å•ã„ã‹ã‘</h2>

  <p>ã€Œã“ã‚Œã‚‰ã®è¡€æ¶²æ¤œæŸ»ã®ã‚µã‚¤ãƒ³ã¯ã€ã¾ã‚‹ã§æœªæ¥ã‚’ã®ããè¦‹ã¦ã„ã‚‹ã‚ˆã†ãªæ„Ÿè¦šã«ãªã‚Šã¾ã™ã€‚ã—ã‹ã—ã€ã“ã‚Œã‚‰ã®ã‚µã‚¤ãƒ³ã¯ã€ã‚ãã¾ã§ã‚‚å‚è€ƒæƒ…å ±ã§ã‚ã‚Šã€å¿…ãšã—ã‚‚æ­£ç¢ºãªè¨ºæ–­ã«ã¤ãªãŒã‚‹ã¨ã¯é™ã‚Šã¾ã›ã‚“ã€‚ã“ã‚Œã‚‰ã®æƒ…å ±ã‚’ã©ã®ã‚ˆã†ã«æ´»ç”¨ã—ã¦ã„ãã¹ãã§ã—ã‚‡ã†ã‹ï¼Ÿ åŒ»å¸«ã¨ã®é€£æºãŒä¸å¯æ¬ ã§ã™ã€‚ãã—ã¦ã€æ‚£è€…è‡ªèº«ãŒç©æ¥µçš„ã«æƒ…å ±ã‚’åé›†ã—ã€ç–‘å•ã‚’æŠ•ã’ã‹ã‘ã‚‹å§¿å‹¢ãŒé‡è¦ã§ã™ã€‚ã‚ãªãŸè‡ªèº«ã¯ã€ã“ã‚Œã‚‰ã®æƒ…å ±ã‹ã‚‰ã©ã®ã‚ˆã†ãªæœªæ¥ã‚’æƒ³åƒã—ã¾ã™ã‹ï¼Ÿã€</p>

  <h2 id=conclusion>çµè«–ã¨è¡Œå‹•å‘¼ã³ã‹ã‘ï¼šæœªæ¥ã¸ã®ä¸€æ­©</h2>

  <p>ä»Šå›ã®è¨˜äº‹ã§ã¯ã€è¡€æ¶²æ¤œæŸ»ã§ã‚ã‹ã‚‹ã‚µã‚¤ãƒ³ã«ã¤ã„ã¦è§£èª¬ã—ã¾ã—ãŸã€‚ã“ã‚Œã‚‰ã®ã‚µã‚¤ãƒ³ã¯ã€ãŒã‚“ã®è¨ºæ–­ã‚„æ²»ç™‚ã®æœªæ¥ã‚’å·¦å³ã™ã‚‹å¯èƒ½æ€§ã‚’ç§˜ã‚ã¦ã„ã¾ã™ã€‚ã—ã‹ã—ã€ã“ã‚Œã‚‰ã®ã‚µã‚¤ãƒ³ã¯ã€ã‚ãã¾ã§ã‚‚å‚è€ƒæƒ…å ±ã§ã‚ã‚Šã€å¿…ãšã—ã‚‚æ­£ç¢ºãªè¨ºæ–­ã«ã¤ãªãŒã‚‹ã¨ã¯é™ã‚Šã¾ã›ã‚“ã€‚ã“ã‚Œã‚‰ã®æƒ…å ±ã‚’æ´»ç”¨ã—ã€åŒ»å¸«ã¨é€£æºã—ãªãŒã‚‰ã€é©åˆ‡ãªæ¤œæŸ»ã‚„æ²»ç™‚ã‚’å—ã‘ã‚‹ã“ã¨ãŒé‡è¦ã§ã™ã€‚ãã—ã¦ã€æ‚£è€…è‡ªèº«ãŒç©æ¥µçš„ã«æƒ…å ±ã‚’åé›†ã—ã€ç–‘å•ã‚’æŠ•ã’ã‹ã‘ã‚‹å§¿å‹¢ãŒé‡è¦ã§ã™ã€‚2025å¹´ã‚’è¦‹æ®ãˆã€æœªæ¥ã¸ã®ä¸€æ­©ã‚’è¸ã¿å‡ºã—ã¾ã—ã‚‡ã†ã€‚</p>

</body>
</html></div>
  <p style="text-align:center; margin-top: 2em;">
    <a href="https://pmc.ncbi.nlm.nih.gov/articles/12345036/" target="_blank">ğŸ‘‰ æŸ¥çœ‹åŸå§‹æ–°è</a>
  </p>
  <script>
    document.querySelectorAll('.lang-btn').forEach(btn => {
      btn.addEventListener('click', () => {
        const lang = btn.dataset.lang;
        document.querySelectorAll('.lang-btn').forEach(b => b.classList.remove('active'));
        btn.classList.add('active');
        document.querySelectorAll('.lang-content').forEach(div => {
          div.style.display = div.dataset.lang === lang ? '' : 'none';
        });
      });
    });
  </script>
</body>
</html>